
Simply Hospitality
GLP-1 Weight Loss Drugs: How Will They Change Hospitality? | Katy Moses
Hospitality insight expert Katy Moses , founder of KAM Insights , joins hosts Lucy and Ruth to unpack one of the biggest emerging trends facing the hospitality industry: the rise of GLP-1 weight loss medications such as Ozempic and Mounjaro. Drawing on consumer research and industry data, Katy explores how these medications could reshape the way people eat, drink and spend their money in hospitality. As one of the UK's leading consumer insight specialists, Katy helps hospitality businesses understand changing customer behaviour before it impacts the market. In this episode, she explains why operators should be paying attention now—and how businesses can adapt to meet changing consumer needs. In this episode, we'll explore: What GLP-1 medications are and why they're becoming one of the biggest talking points in hospitality. How weight loss drugs could change the way customers order food, alcohol and drinks when eating out. Why the industry should see this as an opportunity to innovate rather than a threat. The growing demand for healthier menus, smaller portions and more mindful dining experiences. How wearable technology, wellbeing and health-conscious lifestyles are influencing consumer behaviour beyond GLP-1 users. Why understanding customer data will help hospitality businesses make smarter menu and marketing decisions. Practical ways restaurants, pubs and cafés can adapt to attract both GLP-1 users and health-conscious consumers in the years ahead. Tune in for an eye-opening discussion on one of the biggest shifts facing hospitality and discover how understanding tomorrow's consumer could give your business a competitive edge today. If you found this episode helpful, we encourage you to follow Simply Hospitality for more conversations with hospitality leaders, chefs and industry experts.

